Advocacy intelligence hub — real-time data for patient organizations
Cotellic: FDA approved
as a single agent for the treatment of adult patients with histiocytic neoplasms
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Patient Assistance Programs1
Cotellic
Genentech, Inc.